Contract award notice
Results of the procurement procedure
Section I: Contracting
authority
I.1) Name and addresses
Cell Therapy Catapult Ltd
12th Floor Tower Wing, Guuy's Hospital, Great Maze Pond
London
SE1 9RT
UK
Contact person: Angela Porter
E-mail: ojeu@ct.catapult.org.uk
NUTS: UK
Internet address(es)
Main address: https://ct.catapult.org.uk/
I.4) Type of the contracting authority
Other: private company limited by guarantee
I.5) Main activity
Other: Cell and Gene Therapy Research
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
This Is a Restricted Process. The Supply of Construction Services for the Cell Gene Therapy Manufacturing Centre Phase 2
Reference number: CON-0104
II.1.2) Main CPV code
71500000
II.1.3) Type of contract
Works
II.1.4) Short description
With Phase 1 due to complete mid 2017, there is a business need to increase the number of modules within the facility from the 6nr completed as part of Phase 1 to 12nr (Phase 2).
Expressions of interest are sought from suitably qualified contractors responding to this SQ PQQ, who will need to demonstrate experience in successfully delivering the fit out of complex, GMP biologics manufacturing projects of the scale and to the programme required for this Project. Cell and Gene Therapy intends to appoint a combined project management and design team to work with CGT to deliver the proposed Phase 2 of the Project.
The Client is looking for contractors who:
— are financially sound,
— have suitable technical skills in respect of design, programming fast-track projects, coordination and integration of design and construction-related activities,
— have, together with their proposed supply chain sub-contractors and suppliers, specific expertise, experience and skills in delivering projects of a similar.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Lowest offer:
9 000 000.00
GBP/ Highest offer:
11 000 000.00
GBP
II.2) Description
II.2.3) Place of performance
NUTS code:
UK
Main site or place of performance:
Stevenage Hertfordshire.
II.2.4) Description of the procurement
The Client is looking for contractors who:
— are financially sound,
— have suitable technical skills in respect of design, programming fast-track projects, coordination and integration of design and construction-related activities,
— have, together with their proposed supply chain sub-contractors and suppliers, specific expertise, experience and skills in delivering projects of a similar nature to the CGT requirement involving the design, commissioning and successful handover.
2 / 4
— possess the necessary skills to obtain and implement any required statutory approvals,
— possess an exceptional health and safety record — our requirement is reflected in the allocated weightings for the questions relating to health and safety within this SQ,
— have managed the design and construction process to deliver similar projects to at least an “Very Good” BREEAM standard,
— are familiar with, and have experience in working to BIM Level 2,
— can provide evidence of their expertise and a proven commitment to delivery within agreed programmes, costs, quality and, most importantly, focused delivery to meet client objectives.
The concept design is currently being developed but the requirement is likely to involve the following as progressed but is likely to include:
— the fit out of approximately 3 000 m2. In addition, there will be an interstitial plant ceiling above the module ceiling plate,
— flexible configuration Grade C Clean room space suitable for Advanced Therapy Medicinal Product manufacture, with the ability to deliver multiple parallel processes for Autologous product manufacturing, and the flexibility to convert the clean spaces to manufacture either Allogeneic products at up to 1 000 L scale, gene modified products or regenerative organs. The clean rooms will also have the flexibility for conversion between Grade C and Grade D classifications,
— potential extension to the existing warehouse and QC facility,
— completion of external works and access road (held over from Phase 1),
— works completed in an occupied building,
— it must achieve the requisite licences for GMP manufacturing from the MHRA and be capable of meeting all regulatory requirements in significant markets worldwide, including US FDA cGMPs,
— it will be based on the Manufacturing module principle developed at the Cell and Gene Therapy Catapult with additional flexible support space.
II.2.5) Award criteria
Quality criterion: The requested information has been supplied and also to carry out the “Pass / Fail” tests to be applied. The evaluation of the Technical Requirements were be based on as
/ Weighting: 70 %
Price
/ Weighting:
30 %
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Restricted procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
No
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2018/S 006-010281
IV.2.9) Information about termination of call for competition in the form of a prior information notice
The contracting authority will not award any further contracts based on the above prior information notice
Section V: Award of contract
Contract No: CON-0104
Title: He Supply of Construction Services for the Cell Gene Therapy Manufacturing Centre Phase 2 Stevenage
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
24/04/2018
V.2.2) Information about tenders
Number of tenders received: 4
Number of tenders received from SMEs: 0
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 4
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Merit Holdings Ltd
3 Silverton Court, Northumberland Business Park
Cramlington
NE23 7RY
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
Lowest offer:
9 000 000.00
GBP
/ Highest offer:
11 000 000.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
In addition to current text also to be clear: This contract was awarded to Merit Holdings Ltd as they were theonly bidder that agreed to Cell & Gene Therapy Catapult Terms & Conditions. As part of the restricted processthese were not negotiable.
VI.4) Procedures for review
VI.4.1) Review body
Cell and Gene Therapy Catapult
London
UK
VI.5) Date of dispatch of this notice
03/06/2018